AACE Rare Diseases and Hormone Disorders Webinar Series is pleased to present Prevention of Aggressive Atherosclerosis Requires Aggressive Diagnosis and Treatment. This webinar is designed to help clinicians create a path to diagnosis when encountering a patient with homozygous familial hypercholesterolemia (HoFH).
This disease was chosen due to its rarity, symptom complexity, and need for improved diagnostic and management strategies. The webinar will provide clinicians with the latest clinical guidance and educational resources for diagnosing, managing, and treating this condition. By highlighting the latest research and clinical advances, AACE aims to increase clinicians’ awareness, knowledge, and competence, ultimately improving the quality of care and outcomes for patients with this rare endocrine disease.
Homozygous Familial Hypercholesterolemia: Prevention of Aggressive Atherosclerosis Requires Aggressive Diagnosis and Treatment will be held on Friday, October 24th at 1:00PM EDT.
View All AACE Rare Diseases and Hormone Disorders Webinars
Coming soon: When Triglycerides Skyrocket: Recognizing and Treating Severe Hypertriglyceridemia
Coming soon: Cortisol Deficiency and Androgen Excess: Navigating the Challenges of CAH
Coming soon: Polycystic Ovary Syndrome10/24/2025
10/03/2026
Upon completion of the program, participants will be able to:
- Describe the diagnostic and testing approach in evaluating a patient with homozygous familial hypercholesterolemia.
- Utilize evidence-based guidelines, algorithms, and consensus statements to diagnose and treat homozygous familial hypercholesterolemia.
- Identify and treat long-term complications and comorbidities of homozygous familial hypercholesterolemia.
Endocrinologists are the primary target audience; however, all health care professionals including primary care physicians, nurse practitioners, nurses, physician associates and endocrine care professionals who treat patients with rare endocrine diseases in their practice may also access this program.
SPEAKERS
FACULTY
Eliot Brinton, MD, FAHA, FNLA, FACE
Past President, American Board of Clinical Lipidology
President, Utah Lipid Center
Salt Lake City, Utah
Lance Sloan, MD, MSE, FACE, FASN, FACP, FEAA, FASPC
Medical Director, Texas Institute for Kidney and Endocrine Disorders
Lufkin, TX
This activity is supported by educational grants from Amgen Inc and Chiesi USA.